TCR γδ cell–specific STAT5 gain of function induces a druggable chronic human immune dysregulation
Journal of Human Immunity · 07.09.2026 · 2 (5)
DOI: 10.70962/jhi.20250175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Human Immunity, online erschienen am 10.08.2026. Verfasst von Benedikt J Meyer und 19 weiteren Autor:innen. Beteiligte Einrichtung: Immunodeficiency Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland. Die Arbeit nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Novartis Foundation, Nora van der Meeuwen-Häfliger Foundation.
Abstract (Originalsprache)
Within a prospective cohort of patients with immune dysregulation, we identified several individuals with chronically increased proportions of TCR γδ cells but normal peripheral lymphocyte counts. Among those, we identified one individual with a TCR γδ cell–specific heterozygous p.Y665F STAT5B gain-of-function mutation. Recurrent oral aphthous lesions, susceptibility to infection, arthralgia, and fatigue, were linked to relatively elevated numbers of γδ T cells expressing a Vγ9Vδ2 TCR, displaying hyperphosphorylation of STAT5 upon in vitro IL-2 stimulation. The TCR Vγ9Vδ2 cells exhibited enhanced proliferative response to (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate and dysregulated cytokine production. The TCR γδ cell transcriptome revealed the suppression of the default Th17 program, along with inhibition of RORC and MAF expression. The JAK inhibitor baricitinib improved clinical features of the observed immune dysregulation and reduced the frequency of peripheral TCR Vγ9Vδ2 cells. Thus, functionally altered TCR γδ cells may underlie chronic immune dysregulation of unknown molecular cause, demonstrated here to be amenable to tailored immune modulation.
Autor:innen und Institutionen
- Immunodeficiency Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
- Experimental Immunology Laboratory, Department of Biomedicine, University of Basel and University Hospital, Basel, Switzerland.
- Functional Genomics Center Zurich, ETH Zurich, and University of Zurich, Zurich, Switzerland.
- Translational Immunology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
- Laboratory Medicine, Division Medical Immunology, University Hospital Basel, Basel, Switzerland.
- Laboratory Medicine, Division Diagnostic Hematology, University Hospital Basel, Basel, Switzerland.
ORCID-Profile: Benedikt J Meyer, José Pedro Loureiro, Vladimir Nosi, Robin Hupfer, Adhideb Ghosh, Fabio Poletti, Annaïse Jauch, Julia Hirsiger, Caroline Berkemeier, Ingmar Heijnen, Jan Dirks, Ilaria Alborelli, Thomas Menter, Alexandar Tzankov, Christoph Hess, Alexander A Navarini, Christoph T Berger, Lucia Mori, Gennaro De Libero, Mike Recher
Förderung
- Swiss National Science Foundation
- Novartis Foundation
- Nora van der Meeuwen-Häfliger Foundation
- Swiss Cancer Research Foundation
- Basel Cancer League
Zitieren
APA
Meyer, B. J., Loureiro, J. P., Nosi, V., Hupfer, R., Ghosh, A., Poletti, F., Jauch, A., Hirsiger, J., Berkemeier, C., Heijnen, I., Dirks, J., Alborelli, I., Menter, T., Tzankov, A., Hess, C., Navarini, A. A., Berger, C. T., Mori, L., De Libero, G., & Recher, M. (2026). TCR γδ cell–specific STAT5 gain of function induces a druggable chronic human immune dysregulation. Journal of Human Immunity, 2(5). https://doi.org/10.70962/jhi.20250175
Vancouver
Meyer BJ, Loureiro JP, Nosi V, Hupfer R, Ghosh A, Poletti F, et al. TCR γδ cell–specific STAT5 gain of function induces a druggable chronic human immune dysregulation. Journal of Human Immunity. 2026;2(5). doi:10.70962/jhi.20250175
BibTeX
@article{Meyer2026,
author = {Meyer, Benedikt J and Loureiro, José Pedro and Nosi, Vladimir and Hupfer, Robin and Ghosh, Adhideb and Poletti, Fabio and Jauch, Annaïse and Hirsiger, Julia and Berkemeier, Caroline and Heijnen, Ingmar and Dirks, Jan and Alborelli, Ilaria and Menter, Thomas and Tzankov, Alexandar and Hess, Christoph and Navarini, Alexander A and Berger, Christoph T and Mori, Lucia and De Libero, Gennaro and Recher, Mike},
title = {TCR γδ cell–specific STAT5 gain of function induces a druggable chronic human immune dysregulation},
journal = {Journal of Human Immunity},
year = {2026},
volume = {2},
number = {5},
doi = {10.70962/jhi.20250175}
}
EUVIMED